TLR4 and neoplasm: The observed Eftud2 overexpression mediates the alternative splicing of components of the Toll-like receptor-4 (TLR4)-MyoD88 pathway required for the activation of NF-κB signalling, which promotes both chronic intestinal inflammation and tumour progression.